Related Experiment Video
Updated: Jul 14, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
Continuous ambulatory peritoneal dialysis and the human immunodeficiency virus
1Department of Medicine, University of Nairobi, P.O Box 19676, Nairobi.
Abstract:
This review looks at the clinical performance of Immunodeficiency Virus (HIV) infected individuals with end stage renal disease (ESRD) treated using continuous ambulatory peritoneal dialysis (CAPD). It also considers the potential infectious nature of the peritoneal dialysis effluent (PDE) and offers suggestions on how to circumvent this risk.
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Peritoneal Dialysis I: Introduction and Procedure
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Hemodialysis I: Introduction
Sexually Transmitted Infections
